Tumor Necrosis Factor-α Inhibitor Use Is Not Associated with Lipid Changes in Rheumatoid Arthritis

被引：4

作者：

Bili, Androniki ^{[1
]}

Morris, Stephanie J. ^{[1
]}

Sartorius, Jennifer A. ^{[1
]}

Kirchner, H. Les ^{[1
]}

Antohe, Jana L. ^{[1
]}

Dancea, Sorina ^{[1
]}

Wasko, Mary Chester ^{[1
]}

机构：

[1] Geisinger Hlth Syst, Dept Rheumatol, Danville, PA 17822 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2012年 / 39卷 / 05期

关键词：

RHEUMATOID ARTHRITIS; LIPIDS; TUMOR NECROSIS FACTOR-alpha INHIBITORS; INFLIXIMAB TREATMENT; INSULIN-RESISTANCE; PROFILE; THERAPY; PATTERNS;

D O I：

10.3899/jrheum.111093

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To determine the association of use of tumor necrosis factor-alpha (TNF-alpha) inhibitors with differences in lipid levels in patients with rheumatoid arthritis (RA). Methods. We studied 807 patients with incident RA to compare differences in lipid levels in TNF-alpha inhibitor users versus nonusers, with adjustment for relevant covariables. Results. TNF-alpha inhibitor use was not associated with differences in levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC), triglycerides, LDL:HDL, or TC:HDL compared to nonusers. Conclusion. Use of TNF-alpha inhibitor was not associated with differences in lipid levels in patients with RA. (First Release April 1 2012; J Rheumatol 2012;39:946-8; doi:10.3899/jrheum.111093)

引用

页码：946 / 948

页数：3

共 50 条

[1] Current tumor necrosis factor-α inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis
Liang, GC
Cordero, M
Dyer, A
Chang, RW
[J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (09) : 1662 - 1665
[2] Tumor Necrosis Factor- Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis
Desai, Rishi J.
Solomon, Daniel H.
Schneeweiss, Sebastian
Danaei, Goodarz
Liao, Katherine P.
Kim, Seoyoung C.
[J]. EPIDEMIOLOGY, 2016, 27 (03) : 414 - 422
[3] Tumor necrosis factor-α antagonist use and cancer in patients with rheumatoid arthritis
Setoguchi, Soko
Solomon, Daniel H.
Weinblatt, Michael E.
Katz, Jeffrey N.
Avorn, Jerry
Glynn, Robert J.
Francis Cook, E.
Carney, Greg
Schneeweiss, Sebastian
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S19 - S19
[4] Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis
Asahina, Akihiko
Ishii, Norihisa
Tohma, Shigeto
[J]. JOURNAL OF DERMATOLOGY, 2012, 39 (02): : 199 - 201
[5] Tumor necrosis factor-α blockade in the treatment of rheumatoid arthritis
Keystone, EC
[J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2001, 27 (02) : 427 - 443
[6] An orally active tumor necrosis factor-α inhibitor drug candidate for the management of rheumatoid arthritis
Sharma, S
Ghosh, U
Jadhav, S
Khan, A
More, T
Ranaware, A
Gadkari, T
Nair, V
Ahmad, I
Dalal, R
Damre, A
Deshmukh, G
Gupte, R
Kulkarni-Almeida, A
Panicker, R
Parikh, S
Perumal, S
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S355 - S355
[7] Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
Desai, Rishi J.
Solomon, Daniel H.
Schneeweiss, Sebastian
Danaei, Goodarz
Liao, Katherine P.
Kim, Seoyoung C.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 213 - 214
[8] Tumor necrosis factor inhibitor therapy for rheumatoid arthritis
Naguwa, SM
[J]. AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 709 - 715
[9] Dosing patterns and costs of tumor necrosis factor inhibitor use for rheumatoid arthritis
Harrison, David J.
Huang, Xingyue
Globe, Denise
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : 1281 - 1287
[10] Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis
Setoguchi, Soko
Schneeweiss, Sebastian
Avorn, Jerry
Katz, Jeffrey N.
Weinblatt, Michael E.
Levin, Raisa
Solomon, Daniel H.
[J]. AMERICAN HEART JOURNAL, 2008, 156 (02) : 336 - 341

← 1 2 3 4 5 →